1. Home
  2. RVPH vs WRAP Comparison

RVPH vs WRAP Comparison

Compare RVPH & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • WRAP
  • Stock Information
  • Founded
  • RVPH 2006
  • WRAP 2016
  • Country
  • RVPH United States
  • WRAP United States
  • Employees
  • RVPH N/A
  • WRAP N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • WRAP Ordnance And Accessories
  • Sector
  • RVPH Health Care
  • WRAP Industrials
  • Exchange
  • RVPH Nasdaq
  • WRAP Nasdaq
  • Market Cap
  • RVPH 88.0M
  • WRAP 91.2M
  • IPO Year
  • RVPH N/A
  • WRAP N/A
  • Fundamental
  • Price
  • RVPH $1.90
  • WRAP $1.95
  • Analyst Decision
  • RVPH Strong Buy
  • WRAP
  • Analyst Count
  • RVPH 5
  • WRAP 0
  • Target Price
  • RVPH $11.40
  • WRAP N/A
  • AVG Volume (30 Days)
  • RVPH 1.7M
  • WRAP 151.7K
  • Earning Date
  • RVPH 11-14-2024
  • WRAP 11-14-2024
  • Dividend Yield
  • RVPH N/A
  • WRAP N/A
  • EPS Growth
  • RVPH N/A
  • WRAP N/A
  • EPS
  • RVPH N/A
  • WRAP N/A
  • Revenue
  • RVPH N/A
  • WRAP $4,231,000.00
  • Revenue This Year
  • RVPH N/A
  • WRAP N/A
  • Revenue Next Year
  • RVPH N/A
  • WRAP N/A
  • P/E Ratio
  • RVPH N/A
  • WRAP N/A
  • Revenue Growth
  • RVPH N/A
  • WRAP N/A
  • 52 Week Low
  • RVPH $0.60
  • WRAP $1.21
  • 52 Week High
  • RVPH $4.83
  • WRAP $4.54
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 58.09
  • WRAP 48.72
  • Support Level
  • RVPH $1.97
  • WRAP $1.95
  • Resistance Level
  • RVPH $2.15
  • WRAP $2.07
  • Average True Range (ATR)
  • RVPH 0.15
  • WRAP 0.12
  • MACD
  • RVPH 0.02
  • WRAP -0.02
  • Stochastic Oscillator
  • RVPH 78.74
  • WRAP 11.11

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

Share on Social Networks: